Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Maynard

Showing results (121-130 of 448) with videos related to

Pageof 45
Sort By:
BMJ (Clinical Research Ed.)|August 10, 1996
Private finance for the public good?D Dawson, A Maynard
The British Journal of Psychiatry. Supplement|November 26, 1998
Building castles on sands or quicksands? The strengths and weaknesses of economic evaluation in pharmaceuticalsA Maynard, K Bloor
BMJ (Clinical Research Ed.)|April 11, 2001
Limits to demand for health care. Rationing is needed in a national health serviceA Maynard, T Sheldon
Journal of Health and Human Services Administration|May 26, 1999
Universal coverage and cost control: the United Kingdom National Health ServiceA Maynard, K Bloor
International Journal of Technology Assessment in Health Care|August 10, 2000
Health technology assessment in Europe. Improving clarity and performanceR Cookson, A Maynard
Health Policy (Amsterdam, Netherlands)|May 29, 2000
Public opinion and rationing in the United KingdomD King, A Maynard
BMJ (Clinical Research Ed.)|August 6, 1994
An outsider's view of the NHS reformsK Bloor, A Maynard
Community Medicine|February 1, 1985
Counting the cost of alcohol: gaps in epidemiological knowledgeR McDonnell, A Maynard
Current Cancer Drug Targets|August 17, 2005
Molecular targets from VHL studies into the oxygen-sensing pathwayM A Maynard, M Ohh
Pharmacoeconomics|May 27, 1999
Computer modelling. The need for careful evaluation and public auditA Maynard, R F Cookson
Pageof 45

Showing results (121-130 of 448) with videos related to

Sort By:
Pageof 45
BMJ (Clinical Research Ed.)|August 10, 1996
Private finance for the public good?D Dawson, A Maynard
The British Journal of Psychiatry. Supplement|November 26, 1998
Building castles on sands or quicksands? The strengths and weaknesses of economic evaluation in pharmaceuticalsA Maynard, K Bloor
BMJ (Clinical Research Ed.)|April 11, 2001
Limits to demand for health care. Rationing is needed in a national health serviceA Maynard, T Sheldon
Journal of Health and Human Services Administration|May 26, 1999
Universal coverage and cost control: the United Kingdom National Health ServiceA Maynard, K Bloor
International Journal of Technology Assessment in Health Care|August 10, 2000
Health technology assessment in Europe. Improving clarity and performanceR Cookson, A Maynard
Health Policy (Amsterdam, Netherlands)|May 29, 2000
Public opinion and rationing in the United KingdomD King, A Maynard
BMJ (Clinical Research Ed.)|August 6, 1994
An outsider's view of the NHS reformsK Bloor, A Maynard
Community Medicine|February 1, 1985
Counting the cost of alcohol: gaps in epidemiological knowledgeR McDonnell, A Maynard
Current Cancer Drug Targets|August 17, 2005
Molecular targets from VHL studies into the oxygen-sensing pathwayM A Maynard, M Ohh
Pharmacoeconomics|May 27, 1999
Computer modelling. The need for careful evaluation and public auditA Maynard, R F Cookson
Pageof 45